Digital Psychotherapeutics Market Report Covers Trends, Demand, Growth and Forecast 2033

In 2023, the global Digital Psychotherapeutics Market is expected to be valued US$ 1.06 billion. Global demand for Digital Psychotherapeutics is expected to grow at a 27.6% CAGR during the next ten years. The overall market value is estimated to exceed US$ 12.2 billion by 2033.

People in various parts of the world have difficulty getting timely access to mental health care. This is owing to a scarcity of in-person psychotherapy treatments and expensive healthcare costs.

This void is being filled by the advent of digital psychotherapy as an alternate treatment delivery technique. Providers can allow patients to receive health treatments from remote regions through digitising and innovating in psychological therapy. This benefits customers by reducing wait times and healthcare expenditures.

Digital Psychotherapeutics is the delivery of mental health care via electronic devices that use the internet. It is also referred to as e-therapy, e-counseling, or online counselling.

The therapy of behavioural, emotional, personality, and psychiatric issues using verbal and nonverbal communication and interventions is referred to as Digital Psychotherapeutics. Digital and internet-based health solutions have seen a surge in popularity in recent years. According to research, this has influenced patient behaviour and improved prognosis.

Digital Psychotherapeutics can be used alone or in conjunction with other traditional treatments such as in-person or pharmaceutical therapy. Several studies have found that digital psychotherapy, particularly cognitive behavioural therapy, can be just as successful as face-to-face therapy.

Key Players in the Digital Psychotherapeutics Industry:

  • SwissDTx
  • Starling Minds
  • Woebot Health
  • Talkspace
  • Pear Therapeutics
  • Ginger
  • Meru
  • Spring Care, Inc.
  • AbleTo, Inc.
  • Novartis
  • SilverCloud Health
  • FlyingPepper
  • BetterHelp

Browse Detail Summary@ https://www.futuremarketinsights.com/reports/digital-psychotherapeutics-market

Global Digital Psychotherapeutics Market Segmentation

By Solution:

  • Monotherapy
  • Combination Therapy

By Application:

  • Prevention
  • Management
  • Treatment

By Business Model:

  • Direct-to-Patients/Consumers
  • Business-to-Business (B2B)

Comments

Post a Comment

Popular posts from this blog

Targeted Therapies for Sandhoff Disease | Assessing the Global Market Landscape

Image
The global Sandhoff Disease Therapeutics Market Size is expected to be worth US$ 10 million in 2023 and US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. From 2018 to 2022, the Sandhoff Disease Treatments market increased at a 4% CAGR. According to the most recent studies, Sandhoff sickness is a rare disorder that affects 1 in 1,000,000 people. The rising demand for these medications is projected to spur the discovery of novel therapies, propelling the market forward in the coming years. Gene therapy is being investigated as a potential treatment for Sandhoff disease. The therapy restores the ability to break down GM2 ganglioside by delivering a functional copy of the missing enzyme into the patient's cells. This has the potential to reduce or stop disease progression while also improving patient quality of life. Key Takeaways from the Market Study   The Sandhoff Disease Therapeutics market increased at a 4% CAGR from 2018 to 2022. From 2023 to 2033, the global Sandh
Read more

A Safer Tomorrow | Emerging Trends in Hospital-Acquired Infection Control Market

Image
According to Future Market Insights' recently released Hospital-acquired Infection Control Market analysis report, global Hospital-acquired Infection Control sales in 2023 are expected to be US$ 6.5 billion. The market is expected to increase at a CAGR of 7% between 2023 and 2033, reaching $12.7 billion by 2033. Hospitals and intensive care units are predicted to create significant income in the market, with a CAGR of 7.6%. The occurrence of hospital-acquired infections, increasing proportion of surgical procedures, growing geriatric population and increasing prevalence of chronic diseases, technological advancements in sterilisation equipment, and growing awareness of environmental and personal hygiene are the key factors driving the Hospital-acquired infection control market. The increased use of e-beam sterilisation, as well as the reintroduction of ethylene oxide sterilisation, is predicted to increase demand for hospital-acquired infection management. The percentage of treatm
Read more

Transforming Trauma | Emerging Therapies and Interventions in Post-Traumatic Stress Disorder Treatment Market

Image
According to Future Market Insights, the Post-Traumatic Stress Disorder (PTSD) Treatment Market Sales would grow at a 5% CAGR between 2023 and 2033. By 2033, the global market for post-traumatic stress disorder (PTSD) therapy is expected to reach US$ 27.37 billion. The market's growth might be attributed to the increased prevalence of PTSD globally. According to the National Centre for PTSD, approximately 7-8% of the US population will develop PTSD at some point in their lives, with greater percentages among military veterans and persons who have experienced sexual assault or other types of trauma. The COVID-19 pandemic has also been highlighted as a possible cause of PTSD, with healthcare workers, first responders, and people immediately impacted by the virus being especially vulnerable. In addition, there is a growing emphasis on using digital therapies and other non-pharmacological techniques to treat PTSD. For example, virtual reality exposure treatment (VRET) has shown potent
Read more